Kindred Biosciences, Inc.KINNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
12.50%
↑ 206% above average
Average (34q)
-11.78%
Historical baseline
Range
High:203.39%
Low:-235.82%
Volatility
-3729.4%
Relatively stable
| Period | Value |
|---|---|
| Q2 2021 | 12.50% |
| Q1 2021 | 17.24% |
| Q4 2020 | 9.38% |
| Q3 2020 | -152.46% |
| Q2 2020 | 203.39% |
| Q1 2020 | -47.50% |
| Q4 2019 | -2.56% |
| Q3 2019 | -5.41% |
| Q2 2019 | 11.90% |
| Q1 2019 | -2.44% |
| Q4 2018 | -5.13% |
| Q3 2018 | 0.00% |
| Q2 2018 | -8.33% |
| Q1 2018 | -2.86% |
| Q4 2017 | -20.69% |
| Q3 2017 | 0.00% |
| Q2 2017 | 3.33% |
| Q1 2017 | -11.11% |
| Q4 2016 | 6.90% |
| Q3 2016 | -16.00% |
| Q2 2016 | 19.35% |
| Q1 2016 | 3.13% |
| Q4 2015 | 11.11% |
| Q3 2015 | -2.86% |
| Q2 2015 | -2.94% |
| Q1 2015 | 0.00% |
| Q4 2014 | -9.68% |
| Q3 2014 | 26.19% |
| Q2 2014 | -10.53% |
| Q1 2014 | -40.74% |
| Q4 2013 | -235.82% |
| Q3 2013 | 4.29% |
| Q2 2013 | -76.84% |
| Q1 2013 | -87.01% |
| Q4 2012 | 0.00% |